West Pharmaceutical Services (WST)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 274,600 | 255,300 | 230,000 | 161,900 | 91,800 |
| Marketable Securities | N/A | N/A | N/A | 12,400 | 26,500 |
| Receivables | 181,400 | 179,000 | 185,700 | 175,000 | 147,200 |
| Inventories | 181,100 | 181,500 | 176,900 | 162,200 | 151,800 |
| Income taxes - deferred | N/A | 7,800 | 15,900 | 7,700 | 7,900 |
| Other current assets | 36,600 | 35,500 | 42,200 | 38,100 | 46,800 |
| TOTAL | $673,700 | $659,100 | $650,700 | $557,300 | $472,000 |
| Non-Current Assets | |||||
| PPE Net | 721,000 | 705,800 | 711,700 | 669,000 | 593,600 |
| Investments And Advances | 61,300 | 60,600 | 60,900 | 59,800 | 56,200 |
| Intangibles | 142,200 | 150,600 | 162,500 | 163,100 | 163,500 |
| Other Non-Current Assets | 96,900 | 93,600 | 85,800 | 114,800 | 113,800 |
| TOTAL | $1,021,400 | $1,010,600 | $1,020,900 | $1,006,700 | $927,100 |
| Total Assets | $1,695,100 | $1,669,700 | $1,671,600 | $1,564,000 | $1,399,100 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 119,800 | 103,100 | 108,000 | 102,900 | 89,800 |
| Accrued Expenses | 53,000 | 52,900 | 59,100 | 56,500 | 45,000 |
| Other current liabilities | 59,400 | 54,400 | 53,000 | 46,300 | 41,000 |
| TOTAL | $314,300 | $252,500 | $236,900 | $261,800 | $243,200 |
| Non-Current Liabilities | |||||
| Long Term Debt | 228,900 | 308,300 | 371,300 | 378,800 | 299,300 |
| Other Non-Current Liabilities | 115,600 | 136,300 | 138,100 | 173,700 | 180,100 |
| TOTAL | $356,900 | $460,300 | $528,300 | $573,300 | $501,000 |
| Total Liabilities | $671,200 | $712,800 | $765,200 | $835,100 | $744,200 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 72,334 | 71,495 | 70,339 | 68,715 | 67,559 |
| Common Shares | 18,100 | 17,800 | 17,600 | 17,200 | 8,600 |
| Retained earnings | 964,600 | 902,200 | 805,000 | 719,900 | 664,500 |
| Other shareholders' equity | -162,600 | -119,300 | -32,200 | -75,900 | -71,500 |
| TOTAL | $1,023,900 | $956,900 | $906,400 | $728,900 | $654,900 |
| Total Liabilities And Equity | $1,695,100 | $1,669,700 | $1,671,600 | $1,564,000 | $1,399,100 |